- Ideally administer the vaccine at least 2 weeks before elective splenectomy or starting immunosuppressive treatments such as chemotherapy.
- Delay vaccination during active chemotherapy or radiation therapy. Resume no earlier than 3 months post-treatment, though longer intervals may be required for certain patients.
- Patients with HIV (symptomatic or asymptomatic) should receive the vaccine as early as possible after diagnosis.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Each 0.5 mL dose of the vaccine contains 25 micrograms of purified capsular polysaccharides from the following 23 pneumococcal serotypes: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F.
This vaccine is recommended for the active immunization of individuals 2 years of age and older, including children, adolescents, and adults, to help protect against pneumococcal disease.
The vaccine is formulated using purified capsular polysaccharides from 23 pneumococcal serotypes that are responsible for approximately 90% of invasive pneumococcal infections. The antigens stimulate an immune response, leading to the production of antibodies that protect against pneumococcal disease.
Routine revaccination is not advised for healthy adults or children.
A second dose may be considered for high-risk individuals after at least 5 years, especially those with conditions like asplenia or nephrotic syndrome.
Revaccination within 3 years is not recommended due to a higher incidence of adverse effects.
Commonly reported side effects include:
Injection site reactions: pain, swelling, redness (up to 60%)
Systemic symptoms: headache (17.6%), fatigue or weakness (13.2%), and muscle pain (11.9%)
Can be given simultaneously with the influenza vaccine, but at separate injection sites using different needles.
Individuals allergic to any vaccine component.
Those with fever, acute infections, or during the acute phase of chronic illness.
Individuals with uncontrolled epilepsy or progressive neurological disorders.
Insufficient data from animal studies on reproductive toxicity.
Use during pregnancy only if needed.
Unknown if excreted in human milk; exercise caution when administering to lactating mothers.
Delay vaccination in cases of significant fever or infection unless the delay poses a greater health risk.
Store at 2°C to 8°C.
Protect from light and do not freeze.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.